APSR2026-173

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP12-003
P80
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1211641-46904-AP12-003_Poster _432989.pdf
Format: PDF Only
16. Interstitial Lung Disease
7

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Hui Zhen Jayne Chan * National University Hospital Respiratory and Critical Care Medicine/Department of Medicine Singapore Singapore
Voon Shiong Ronnie Tan - Ng Teng Fong General Hospital Respiratory and Critical Care Medicine/Department of Medicine Singapore Singapore
Mei Luan Valencia Lim - National University Hospital Respiratory and Critical Care Medicine/Department of Medicine Singapore Singapore
Lynette Teo - National University Hospital Department of Diagnostic Imaging Singapore Singapore
Ching Ching Ong - National University Hospital Department of Diagnostic Imaging Singapore Singapore
Ju Ee Seet - National University Hospital Department of Pathology Singapore Singapore
Tow Keang Lim - National University Hospital Respiratory and Critical Care Medicine/Department of Medicine Singapore Singapore
 
 
 
 
 
 
 
 
Presenting Author Details
Hui Zhen Jayne
Chan
jayne.chan@mohh.com.sg
+6587728907
Under 30
Singapore
Original Research
Longitudinal performance of Bayesian multidisciplinary team diagnosis in interstitial lung disease
Maximum 25 words
Abstract Content
Bayesian reasoning—integrating clinical pre‑test probability with radiologic and pathologic data—underpins multidisciplinary team (MDT) diagnosis in interstitial lung disease (ILD). While early implementation reduced unclassifiable ILD, evolving nomenclature, particularly recognition of airway‑centred fibrosing phenotypes labelled as hypersensitivity pneumonitis or bronchiolocentric interstitial pneumonia, may influence diagnostic certainty (Ryerson C et al, AJRCCM, 2025, 211, 1756–1774). Thus, we evaluated the longitudinal stability of our MDT performance against evolving terminology.
We compared two sequential ILD cohorts, assessed by the same MDT at a single tertiary centre: an implementation cohort (2015–June 2019; n=145) and a subsequent cohort (July 2019–2025; n=177). Diagnoses were assigned an ILD category and confidence level using a five‑tier scale. Outcomes included rates of IPF/UIP, unclassifiable ILD, high‑confidence diagnoses (≥70%), and attribution of airway‑centered disease.
Definitive IPF/UIP diagnoses remained stable, comprising 25–26% of early‑cohort cases and 16–21% from 2019–2024. After an initial decline in unclassifiable ILD from 17% to 8% during MDT implementation, it rose in the subsequent cohort. High‑confidence diagnoses decreased from 75% in late 2019 to 32% in 2024 and 22% in 2025, paralleling an increase in unclassifiable ILD to 44% in 2025. Airway‑centred fibrosing patterns accounted for 60% of unclassifiable cases in 2025, compared with minimal attribution in 2015–2019.
While MDT performance in identifying classic fibrotic patterns such as IPF remains robust, rising diagnostic uncertainty reflects evolving case selection and ILD terminology - particularly changes affecting airway‑centred fibrosing disease and the decoupling of morphologic patterns from causal labels. Consensus on interpretation of airway‑centred patterns is needed to maintain diagnostic precision in ILD.
 
 
 
 
 
Yes
No
 
JPG or JPEG or PNG format ONLY
Multidisciplinary team, Bayesian, hypersensitivity pneumonitis
maximum 3 keywords and no abbreviations, separated by commas
 
275